Astrana Health IncASTH

ASTH current price
$37.63+4.09%

Capital at risk.

1W
-9.85%
1M
-11.58%
3M
-31.72%
6M
-5.93%
1Y
+4.09%
MAX
+755.23%
About Astrana Health Inc
Ticker
info
ASTH
Trading on
info
NASDAQ
ISIN
info
US03763A2078
Industry
info
Medical Care Facilities
Sector
info
Healthcare
CEO
info
Brandon K. Sim M.S.
Headquarters
info
1668 S. Garfield Avenue, Alhambra, CA, United States, 91801
Employees
info
1,800
Website
info
astranahealth.com
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Metrics
BasicAdvanced
Market cap
info
$1.76B
P/E ratio
info
29.03
EPS
info
$1.30
Dividend Yield
info
0.00%
Beta
info
1.24
Forward P/E ratio
info
0
EBIDTA
info
$109M
Ex dividend date
info
-
Price & volume
Market cap
info
$1.76B
Average daily volume
info
0.3M
90-day return
info
-31.72%
30-day return
info
-11.58%
7-day return
info
-9.85%
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
29.03
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
29.03
Price to sales
info
1.02
Price to book
info
2.49
Earnings
EPS
info
$1.30
EPS estimate (current quarter)
info
$0.32
EPS estimate (next quarter)
info
$0.23
EBITDA
info
$109M
Revenues (TTM)
info
$1.72B
Revenues per share (TTM)
info
$36.42
Technicals
Beta
info
1.24
52-week High
info
$63.20
52-week Low
info
$34.11
50-day moving average
info
$50.67
200-day moving average
info
$45.78
Short ratio
info
4.86
Short %
info
6.24%
Management effectiveness
ROE (TTM)
info
10.26%
ROA (TTM)
info
4.49%
Profit margin
info
3.63%
Gross profit margin
info
$199M
Operating margin
info
5.94%
Growth
Quarterly earnings growth (YoY)
info
29.80%
Quarterly revenue growth (YoY)
info
37.50%
Share stats
Outstanding Shares
info
45.7M
Float
info
35.7M
Insiders %
info
23.70%
Institutions %
info
46.03%
Analyst Insights & forecasts
info

91% Buy

9% Hold

0% Sell

Based on information from 11 analysts.

Average price target

info
$67.11
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.26
$0.15
73.33%
Q4 • 23Beat
$0.31
$0.30
3.33%
Q1 • 24Beat
$0.40
$0.39
2.56%
Q2 • 24Beat
$0.33
$0.32
3.13%
Q3 • 24Beat
-
$0.21
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$486M
$19.2M
3.94%
Q2 • 24
$479M
$16.1M
3.36%
Q3 • 24
1.55%
16.05%
14.73%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.25B
$774M
61.78%
Q2 • 24
$1.29B
$778M
60.55%
Q3 • 24
2.63%
0.58%
1.99%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$23.2M
$-79.9M
$47.3M
$20.4M
Q2 • 24
$34M
$-8.1M
$-3.2M
$31.7M
Q3 • 24
46.55%
89.86%
106.75%
55.69%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Greed

+1.5

0.75

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Astrana Health Inc share?
Collapse

Astrana Health Inc shares are currently traded for $37.63 per share.

How many shares does Astrana Health Inc have?
Collapse

Astrana Health Inc currently has 45.7M shares.

Does Astrana Health Inc pay dividends?
Collapse

No, Astrana Health Inc doesn't pay dividends.

What is Astrana Health Inc 52 week high?
Collapse

Astrana Health Inc 52 week high is $63.20.

What is Astrana Health Inc 52 week low?
Collapse

Astrana Health Inc 52 week low is $34.11.

What is the 200-day moving average of Astrana Health Inc?
Collapse

Astrana Health Inc 200-day moving average is $45.78.

Who is Astrana Health Inc CEO?
Collapse

The CEO of Astrana Health Inc is Brandon K. Sim M.S..

How many employees Astrana Health Inc has?
Collapse

Astrana Health Inc has 1,800 employees.

What is the market cap of Astrana Health Inc?
Collapse

The market cap of Astrana Health Inc is $1.76B.

What is the P/E of Astrana Health Inc?
Collapse

The current P/E of Astrana Health Inc is 29.03.

What is the EPS of Astrana Health Inc?
Collapse

The EPS of Astrana Health Inc is $1.30.

What is the PEG Ratio of Astrana Health Inc?
Collapse

The PEG Ration of Astrana Health Inc is 0.

What do analysts say about Astrana Health Inc?
Collapse

According to the analysts Astrana Health Inc is considered a buy.

Astrana Health Inc news